ARTA
ASND icon

A.R.T. Advisors’s Ascendis Pharma A/S ASND Stock Holding History

A.R.T. Advisors’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,483
Closed -$344K – 1301
2018
Q4 		$344K Sell
5,483
-13,590
-71% -$854K 0.02% 875
2018
Q3 		$1.35M Buy
19,073
+4,500
+31% +$310K 0.06% 454
2018
Q2 		$969K Sell
14,573
-9,300
-39% -$612K 0.04% 643
2018
Q1 		$1.56M Buy
23,873
+7,630
+47% +$429K 0.06% 491
2017
Q4 		$650K Buy
+16,243
New +$591K 0.03% 785

Other funds holding ASND

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

A.R.T. Advisors's ASND Position: Q1 2019 in Review

A.R.T. Advisors sold out of Ascendis Pharma A/S (ASND) in Q1 2019, closing a stake of 5,483 shares — an estimated $344K sold.

A.R.T. Advisors first reported a position in ASND in Q4 2017 and held it in 5 quarters. The position peaked at $1.56M in Q1 2018. 138 funds tracked by Wall St. Rank hold ASND as of Q1 2019.

  • A.R.T. Advisors reported no remaining Ascendis Pharma A/S position as of Q1 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 5,483 Ascendis Pharma A/S shares in Q1 2019, an estimated $344K.
  • A.R.T. Advisors first reported a position in Ascendis Pharma A/S in Q4 2017 and held it in 5 quarters.
  • A.R.T. Advisors's Ascendis Pharma A/S position peaked at $1.56M in Q1 2018.
  • 138 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2019.

Based on A.R.T. Advisors's 13F filing for Q1 2019, filed 15 May 2019.